article thumbnail

What can Rishi Sunak do for the UK’s pharma industry

Pharmaceutical Technology

At the time of its publication, the document prioritised the finalisation of Brexit above all else. For the life sciences and pharmaceutical sector, the Conservative government promised £34 billion ($38.98 of gross domestic product (GDP) in R&D by 2027. UK’s competitive potential.

article thumbnail

The Inflation Reduction Act: The Impact of Medicare Negotiation of Prescription Drug Prices on Hospitals and Health Systems

Omnicell

Starting next year, Medicare will negotiate directly with pharmaceutical companies to set the maximum fair price (MFP) for certain prescription drugs, with the application of the negotiated prices starting in 2026 for 10 negotiation-eligible drugs from Part D. ” Sen. John Barrasso (R-Wyo.) Impact on 340B?